1. A society for the research of Neuropathy in Korean Diabetes Association. Clinical Practice of Diabetic Neuropathy. 2nd ed. Seoul: Korean Diabetes Association. 2007:1–48.
2. Dyck PJ, Kratz KM, Karnes JL, et al. The Prevalence by Staged Severity of Various Types of Diabetic Neuropathy, Retinopathy, and Nephropathy in a Population-based Cohort : The Rochester Diabetic Neuropathy Study. Neurology. 1993;43(4):817–24.
3. Kim SS, Won JC, Kwon HS, et al. Prevalence and Clinical Implications of Painful Diabetic Peripheral Neuropathy in Type 2 Diabetes : Results froma Nationwide Hospital-based Study of Diabetic Neuropathy in Korea. Diabetes Res Clin Pract. 2014;103(3):522–9.
4. Boulton AJ, Gries FA, Jervell JA. Guidelines for the Diagnosis and Outpatient Management of Diabetic Peripheral Neuropathy. Diabet Med. 1998;15(6):508–14.
5. Ziegler D, Nowak H, Kempler P, Vargha P, Low PA. Treatment of Symptomatic Diabetic Polyneuropathy with the Antioxidant Alpha-lipoic Acid : A Meta-analysis. Diabet Med. 2004;21(2):114–21.
6. Keen H, Payan J, Allawi J, et al. Treatment of Diabetic Neuropathy with Gamma-Linolenic Acid. The Gamma-Linolenic Acid Multicenter Trial Group. Diabetes Care. 1993;16(1):8–15.
7. Jeon EJ, Kwon HJ, Shin IH, Jung ED, Kang SB, Shon HS. Efficacy of Saam Acupuncture for Diabetic Peripheral Neuropathy-A Pilot, Randomized Controlled Study. Korean J Acupunct. 2013;30(4):289–97.
8. Kwon YK, Choi KR, Lee JS, et al. Two Cases of Diabetic Peripheral Polyneuropathy Improved by Bogan-tang. J Korean Oriental Med. 2002;23(1):170–6.
9. Park SK, Kwon EH, Shin HC, Kang SB. One Case of Diabetic Peripheral Polyneuropathy Improved by Binsosan-gamibang. Korean J Orient Int Med. 2005;26(4):935–40.
10. Yang YS. Effect of Serum HbA1c and Duration of Diabetes Mellitus on Diabetic Peripheral Neuropathy [dissertation]. Gwangju: Chonnam National Univ. 2000:Korean.
11. UK Prospective Diabetes Study (UKPDS) Group. Intensive Blood-Glucose Control with Sulphonylureas or Insulin Compared with Conventional Treatment and Risk of Complications in Patients with Type 2 Diabetes (UKPDS 33). Lancet. 1998;352(9131):837–53.
12. Morley S, Pallin V. Scaling the Affective Domain of Pain : A Study of the Dimensionality of Verbal Descriptors. Pain. 1995;62(1):39–49.
13. Feldman EL, Stevens MJ, Thomas PK, Brown MB, Canal N, Greene DA. A Practical Two-step Quantitative Clinical and Electrophysiological Assessment for the Diagnosis and Staging of Diabetic Neuropathy. Diabetes Care. 1994;17(11):1281–9.
14. Ross MA. Neuropathies Associated with Diabetes. Med Clin North Am. 1993;77(1):111–24.
15. Halat KM, Dennehy CE. Botanicals and Dietary Supplements in Diabetic Peripheral Neuropathy. J Am Board Fam Pract. 2003;16(1):47–57.
16. Chun SW, Ko KS. Summary of the Update to the Diabetic Neuropathy Management Guidebook. J Korean Diabetes. 2012;13(3):115–23.
17. Kang MS, Kim CH. Management of Diabetic Peripheral Neuropathy. Korean J Med. 2015;89(3):277–81.
18. Doo HK. Internal Medicine of Kidney in Oriental Medicine. Seoul: Institute of Oriental Medicine. 1991:969–76.
19. Kim JM, Youn SS, An SH, et al. Overview of Diabetic Peripheral Neuropathy and Need for Therapeutic Strategy using Traditional Korean Medicine. J Korean Oriental Med. 2009;30(5):127–36.
21. Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HA. 10-year Follow-up of Intensive Glucose Controlin Type 2 Diabetes. N Engl J Med. 2008;359(15):1577–89.
22. Wall PD, Melzack R. Textbook of Pain. Seoul: Jungdam. 2002:483–4.
23. Lunetta M, Le Moli R, Grasso G, Sangiorgio L. A Simplified Diagnostic Test for Ambulatory Screening of Peripheral Diabetic Neuropathy. Diabetes Res Clin Pract. 1998;39(3):165–72.
25. Moghtaderi A, Bakhshipour A, Rashidi H. Validation of Michigan Neuropathy Screening Instrument for Diabetic Peripheral Neuropathy. Clin Neurol Neurosurg. 2006;108(5):477–81.
26. Choi HY, Do HJ, Oh SW, et al. The Validity of Michigan Neuropathy Screening Instrument as a Screening Test and Risk Factors for Diabetic Peripheral Neuropathy. J Korean Acad Fam Med. 2007;28(8):610–5.